Calpain contributes to silica-induced I kappa B-alpha degradation and nuclear factor-kappa B activation

被引:59
|
作者
Chen, F
Lu, YJ
Kuhn, DC
Maki, M
Shi, XL
Sun, SC
Demers, LM
机构
[1] PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT PATHOL,HERSHEY,PA 17033
[2] PENN STATE UNIV,MILTON S HERSHEY MED CTR,COLL MED,DEPT MICROBIOL & IMMUNOL,HERSHEY,PA 17033
[3] NAGOYA UNIV,SCH AGR SCI,DEPT APPL BIOL SCI,CHIKUSA KU,NAGOYA,AICHI 46401,JAPAN
[4] NIOSH,PATHOL & PHYSIOL RES BRANCH,MORGANTOWN,WV 26205
关键词
silica; NF-kappa beta; I kappa beta alpha; calpain;
D O I
10.1006/abbi.1997.0132
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both silica and lipopolysaccharide (LPS) induce a rapid degradation of I kappa B alpha, an intracellular inhibitor of the nuclear factor (NF)-kappa B transcription factor, In this report, we demonstrate that MG132, a relatively specific proteasome inhibitor, is capable of suppressing LPS-induced I kappa B alpha degradation and NF-kappa B activation in mouse macrophage line RAW 264.7 cells, but is unable to influence the same induction produced by silica. In contrast, the lysosome inhibitor chloroquine has little effect on I kappa B alpha degradation induced by either silica or LPS, In fact, chloroquine enhances the signal-induced nuclear expression of NF-kappa B p50/p65 heterodimer by inhibiting the resynthesis of I kappa B alpha. With the use of transient transfection of a plasmid that expresses calpastatin, a natural inhibitor for calpain, the silica induced degradation of I kappa B alpha and NF-kappa B activation was attenuated. In contrast, no inhibition of LPS-induced I kappa B alpha degradation and NF-kappa B activation was observed by the overexpression of calpastatin. This suggests that calpain contributes to silica-induced I kappa B alpha degradation and NF-kappa B activation but not to LPS-induced I kappa B alpha degradation and NF-kappa B activation. (C) 1997 Academic Press.
引用
收藏
页码:383 / 388
页数:6
相关论文
共 50 条
  • [1] Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
    Imbert, V
    Rupec, RA
    Livolsi, A
    Pahl, HL
    Traenckner, EBM
    MuellerDieckmann, C
    Farahifar, D
    Rossi, B
    Auberger, P
    Baeuerle, PA
    Peyron, JF
    CELL, 1996, 86 (05) : 787 - 798
  • [2] MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappa B activation and degradation of I kappa B-alpha
    Hirano, M
    Osada, S
    Aoki, T
    Hirai, S
    Hosaka, M
    Inoue, J
    Ohno, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) : 13234 - 13238
  • [3] Nuclear factor-kappa B activation in silica-induced interleukin 8 production by human bronchial epithelial cells
    Desaki, M
    Takizawa, H
    Kasama, T
    Kobayashi, K
    Morita, Y
    Yamamoto, K
    CYTOKINE, 2000, 12 (08) : 1257 - 1260
  • [4] Mesalamine modulates nuclear factor-kappa B/I kappa B-alpha in Caco-2 cells: A novel mechanism of action.
    Yang, F
    deVilliers, WJS
    McClain, CJ
    Varilek, GW
    GASTROENTEROLOGY, 1997, 112 (04) : A1125 - A1125
  • [5] Regulation of nuclear factor-kappa B inhibitor I kappa B alpha by nitric oxide donors
    Spiecker, M
    Peng, HB
    Liao, JK
    CIRCULATION, 1997, 96 (08) : 2811 - 2811
  • [6] Regulation of nuclear factor-kappa B and its inhibitor I kappa B-alpha/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis
    Toossi, Z
    Hamilton, BD
    Phillips, MH
    Averill, LE
    Ellner, JJ
    Salvekar, A
    JOURNAL OF IMMUNOLOGY, 1997, 159 (08): : 4109 - 4116
  • [7] Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression
    KretzRemy, C
    Mehlen, P
    Mirault, ME
    Arrigo, AP
    JOURNAL OF CELL BIOLOGY, 1996, 133 (05): : 1083 - 1093
  • [8] Nuclear factor-kappa B activation in intracerebral hemorrhage
    Hickenbottom, SL
    Aronowski, J
    Grotta, RSJC
    NEUROLOGY, 1998, 50 (04) : A370 - A370
  • [9] Nuclear factor-kappa B activation in silica-induced interleukin-8 production by human bronchial epithelial cells.
    Desaki, M
    Takizawa, H
    Yamamoto, K
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A178 - A178
  • [10] Nuclear Factor-kappa B dependent Akt activation contributes to chemoresistance in human cholangiocarcinoma
    Meng, F
    Bleeker, G
    Henson, R
    Taffetani, S
    Lusby, J
    Patel, T
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 366A - 367A